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Before I begin, I want to add my own personal reminiscence. I knew Dave Hume for almost 14 
years, slightly for the first 4 and well for the last 10. I first talked to him at an elevator en-
trance at the Greenbrier Hotel in West Virginia, in April, 1959, and for the last ti!1le in April, 
1973, in the lower lobby of the Century Plaza Hotel in Los Angeles. In May, 1973, I was in the 
railroad station in Albuquerque. New Mexico, when I learned from my grief-stricken youngest 
son that Dave was dead. It is strange h'ow the exact details of these and some other memories 
in between. of the time I spent with Dave Hume, stand out with the same clarity as what I was 
doing when I learned of the bombing of Pearl Harbor, the assassination of John Kennedy, but 
very few other things. The most eloquent tribute to Dave Hume I have heard was the briefest, 
coming from a non-medical friend who told me sadly, "He really was a dynamite guy!" 
THERE IS almost no aspect of clinical 
organ transplantation into which Dave 
Hume did not breathe life. Liver trans-
plantation was no exception. It will surprise 
no one that his contributions were impor-
tant and concisely stated, although never 
published. He gave his observations to one 
of us (T.E.S.) as personal communications 
throughout the years and granted permis-
sion for their use in a book published 5 
years ago. I They should be listed briefly. 
~ H ume performed one of the earliest 
l auxiliary hepatic transplantations, to the 
splenic fossa of a recipient whose abdomen 
could not accommodate the extra organ 
. plus the host liver. Undaunted, he pro-
ceeded to remove the total native liver. In 
another trial, this time with orthotopic 
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transplantation, H ume described hyper-
acute rejection, which if it was a valid diag-
nosis was the first and only documented 
example of this complication destroying a 
liver homograft. Finally, one of Hume's 
recipients who had a hepatoma plus cir-
rhosis lived for about a year postoperatively 
after liver replacement, eventually dying 
with widespread metastases similar to those 
we have recorded after hepatic transplanta-
tion for the indication of malignancy. J 
There is no point in saying more about 
these experiences of H ume, since, important 
as they were, they were really peripheral to 
his main interests. Instead, I would like to 
discuss three aspects of orthotopic liver 
transplantation that might introduce either 
new data or new ideas. These concern our 
survival statistics, hyperacute rejection in 
livers, and the problem of biliary duct 
reconstruction. 
SURVIVAL STATISTICS 
According to the April 1974 report on 
liver transplantation being prepared by Dr. 
Carl G. Groth for the American College 
. of Surgeons Registry, about 200 patients 
have had liver replacement. 2 Since 1963 we 
have contributed 82 to this total, at a rate 
since 1967 ranging from 6 to 13 per year 
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Table 1. CaH' of Orthotopic Liver Tran.plantation 
Tr_ted in Denver 
Lived 
Years Number 1 year 2 years Alive Now 
1963-1966 6 0 0 0 
1967 6 1 0 0 
1968 12 5 2 0 
1969 6 2 
1970 10 2 1 1 
197' 11 2 2 2 
1972 11 5 3 3 
1973 13 0 3 
1974 (to April 1) 7 0 0 3 
82 18 9 13 
(Table I). We have had 18 and 9 recipients, 
respectively, who have lived for more than I 
and 2 years. Thirteen recipients are still 
alive from 2 weeks to almost 5 years post-
operatively. The 4 longest survivors are 4 
years, 10 months; 4 years, 4 months; 3 
years, IO months; and 3 years, 2 months. 
There have been 10 late deaths, from 12 
to 41 months postoperatively, and for the 
reasons listed in Table 2. The latest mor-
tality was at 3 years, 5 months, following a 
bout of Hemophilus septicemia (OT 19). The 
homograft arteries contained the same kind 
of occlusive lesions that have been seen in 
renal transplants. 3 
The causes for the high acute failure rate 
have been discussed elsewhere. I The single 
most important factor has been a multi-
plicity of technical misadventures of which 
complications of biliary duct reconstruction 
lead the list (see next section). Poor control 
of rejection and systemic infection are the 
next leading causes of death. 
THE STRATEGY OF BILE 
DUCT RECONSTRUCTION 
As was just mentioned, the Achilles' heel 
of liver transplantation has been biliary 
duct reconstruction. The different tech-
niques we have used to restore bile drainage 
include choledochocholedochostomy with 
or without a T tube (not applicable with 
biliary atresia), cholecystoduodenostomy 
after ligation of the graft common duct, 
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Table 2. Present Statu. of 18 One-Vear Survivors 
after Orthotopic Liver T ran.plantation. Eight Are 
Still Alive from 14 to 58 Month •• The Other 10·"------..:,--
eventually Died from the Cause. U.ted Below 
OT Time of Death 
Number (month.) Cause of Death 
15 12 Recurrent cancer 
29 12 Serum hepatitus and liver failure 
8 13 Recurrent cancer 
S8 1312 ? Chronic rejection 
? Recurrent hepotitus 
16 1312 Rejection and liver failure 
14 14 Recurrent cancer 
54 19 Multiple liver abscesses neces-
sitating retransplantation 
36 20 Systemic Nocardia infection and 
chronic aggressive hepatitis 
13 30 Rejection and liver failure follow-
ing retransplantation 
19 41 Hemophilus septicemia and secon-
dary liver and renal failure 
and choledochoduodenostomy. Because of 
continuing dissatisfaction with all of the 
aforementioned techniques of duct recon-
struction, we have recently embarked on a-
trial of Roux-en-Y cholecystojejunostomy-::'? 
(see later under Possible Solutions). The .. 
lethal complications with most or all of. ,. 
these procedures were of two general kinds, 
one obvious and proved and the other' 
subtle and still speCUlative. 
Statement o/The Problem 
Mechanical problems. The obvious' 
iary duct problems have been 
and biliary fistula from anastomotic 
In our 82 cases of orthotopic liver 
plantation the initial biliary 
was eventually shown to be rm;i:nl:;lil~irl 
leading either to death or early r ........ ' ... t"nft 
in 25 cases (Table 3), for the 
incidence of 30%; the true frequency 
undoubtedly even higher, since 
tients died so early postoperatively 
incipient duct problem would not yet 
been manifest. In 13 of the 25 •• ",i ... "." 
effort was made at secondary repair. 
in these 13 reoperated cases the biliary 
problem was an important contn 
the main cause of death in at least 9.-
c 
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Table 3. Kind of Primary Bile Duct Recon,tNction Used in 
82 Consecutive Case, of Orthotopic Uver Transplantation 
Roux· .... V Cholecysto· 
Cholecystoduo· Choledochocho- Cholecystoje- Choledochoduo· loop 
denostomy ledochostomy junostomy d.nostomy Jejunostomy Total 
Number 59 9 8 
" 
2 82 
Obstruction 15 0 2 0 0 17* 
Fistula 2 5 0 0 8* 
"In these 25 cases, reoperatians were performed in 13 patients with attempt at duct reconstNction. A satisfactory reo 
cowry followed in only" of the recipients. Two later died after 6 and 1P~ months post·transplantation survival. The other 
2 are alive after 3 months 0 nd 2 years, respectiwly. 80th survivors now hove the final biliary duct reconstruction shown in 
Fig.2C. 
None of the commonly used methods of 
biliary duct reconstruction was trouble-free 
(Table 3). With cholecystoduodenostomy, 
. fistulae were uncommon, but obstruction 
occurred in 25% of cases. The obstructions 
ranged from accidental acute ligation of the 
cystic duct before performing cholecysto-
duodenostomy (Fig. IA) to delayed ob-
struction (Fig. I B) of the cystic duct in 
some cases, apparently due to cytomegalo-
virus (CMV) infection weeks or months 
Homograft liver 
A 
postoperatively.4 Most commonly, no obvi-
ous etiologic cause was evident, accounting 
for the partial cystic duct obstruction. With 
choledochocholedochostomy or choledo-
cnoduodenostomy the leading complication 
was biliary fistula formation. 
There were two obstructions with Roux-
en-Y cholecystojejunostomy. In one, the 
kind of cystic duct ligation shown in Fig. 
I A had not been recognized and was not 
diagnosed until autopsy. In the other case, 
Fig. 1. Two kinds of biliary duct obstruction aher cholecystoduodenOltomy. (A) The anatomic basis for a 
technical error that cost the life of 3 patienh. Distal ligation of the double-barreled extrahepatic duct sy,tem re-
sulted in total biliary obstNetion. This recurrent accident has caused us to perform cholangiography· on all liver--
, homografts before transplantation. (B) The kind of biliary obstruction caused by stenOlis of the cystic duct. 
Martineau reported that cytomegaloviNs infection of the duct could be responsible for this development.4 . 
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Fig. 2. Schomatic repre .. ntatlon of tho bactorial contamination or lack thoreof In three different kind. of 
biliary reconstruction. I AI Cholecystoduodonostomy. Thi. oxtremoly simplo operation prebably carrio. tho .reatest ' 
risk of graft infection. I I) Roux .. n-Y cholecystolojunostomy. This operation protects from hopatle .. pII. by pi_ 
ing tho now livo, outsldo tho main laatrolntostlna' 't .... m. Tho IlOperi.taltle 11mb I, mad. at loa.t II In. long,' 
Ic) Roux-on-Y cholodochojolunOitomy. Tho ond-t .. ond duet-t .. bawol anastomosl. I, simplo If tho duct I, di-
lated, as would be tho ca .. if a conversion became neco .. ary from I to C. . . 
there was partial obstruction (Fig. 3B) of 
the cystic duct necessitating conversion of 
the ultimate hookup shown in Fig. 2e. 
Special bacteriologic complications. With 
the well-defined technical complications 
cited above, clinical evidence of cholangitis 
(including bacteremia) is easily understand-
able and is often accompanied by histo-
pathologic findings of cholangitis. In addi-
tion. a subtle and as yet hypothetical 
complication may occur in spite of an ap-
parently satisfactory biliary duct 
struction. It has been reported by us 
systemic infection and even 
bacteremia are common problems in 
recipients. 1 For years there has been 
justification to believe that the 
liver itself was the portal of entry by 
microorganisms of all kinds gained 
to the bloodstream. The variety of u .. ~ •• w-··".. 
that were cultured from peripheral 
patients, both early and many months 
ci~ 
2E 
ve 
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lis 
be 
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ORTHOTOPIC LIVER TRANSPLANTATION 133 r: 
Fig. '3. Post-transplantation cholangiographic Itudiel. (A) Intra"enoul cholangiogram in a 47-year-old Fe-
dpient of a hepatic homograft, tho biliary drainage for which wal with Raux .. n-Y cholecystojejunostomy (Fig. 
21). The patient'lliver function Itudiel were nonnal at tho time of the examination. Howe"er, the findings of a 
"ery slightly dilated common duct and air In tho biliary IYltem (alTOwl) are IUlpicious for low-grado obstruc-
tion. (B) A percutaneoUI tranlhepatic cholangiogram performed 4 w_ks palt-transplantation because of por-
siltent olo"ationl of the sorum bilirubin (8-10 mgll 00 ml). At the time of tranlplantotion, biliary drainage had 
boon ostablished with a Roux ... n-Y cholecystojejunaltomy (Fig. 21). After obtaining thilltudy, tho pationt wal 
_xplored, tho gallbladder remo"ed, and tho Roux limb analtomoled to the dilated common duct (large ar-
, raw), as shown in Fig. 2C. Tho pationt's jaundice rapidly cleared, and he now hal normal Ii"er function 3 
months post-tranlplantation. GI, gallbladdor; CD, cammon bile duct; C, cystic duct . 
.operation, was strikingly similar to that 
found in dogs and pigs subjected to liver in-
or hepatic transplantation.5 In the hu-
man liver recipients with bacteremia the 
failure to find any other focus of infection 
necessitated indictment of the homograft 
a site of entry) by the process of exclu-
sion. The two routes of entry could be the 
portal vein or the duct system, but the 
possibility seems less and less im-
rtant. 
The exposed relation of the duct system 
the orthotopic liver to gastrointestinal 
flora is probably the first step in bacterial 
through the homograft, which may 
be bacteriologically porous without the 
presence of histopathologically significant 
cholangitis. This situation after cholecysto-
duodenostomy is depicted in Fig. 2A. If 
bacteria enter the circulation through the 
duct system of hepatic homografts, the logi-
cal solution would be to carry out liver 
transplantation as far removed from the 
mainstream of the gastrointestinal tract as 
is possible, as has been illustrated in Figs. 
28 and 2C. 
Practical Solutions 
The five guiding principles we are now at-
tempting to follow are: (I ) avoidance of_ 
stents or drains; (2) preservation of maxi-
mum extrahepatic biliary duct tissue; (3) in-
I" 
! 
! 
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tensification of diagnostic efforts to differ-
entiate between duct obstruction and 
rejection, including performance of cholan-
giography in all homografts prior to trans-
plantation; (4) early reoperation for suspi-
cion of obstruction; (5) placement of the 
liver in a relatively bacteria-free relation to 
the mainstream gastrointestinal continuity. 
None of the presently available operations 
completely meets all of these objectives, so 
that considerable individualization of care 
is necessary. 
A Roux-en- Y cholecystojejunostomy 
(Fig. 28), our present procedure of choice, 
permits all the above listed objectives to be 
partly met. If postoperative biliary obstruc-
tion later develops, the Roux limb can be 
detached, the gallbladder removed, and an 
anastomosis performed to the now dilated 
common duct (Fig. 2C). 
The most important objection to this ap-
proach is that a Roux-en-Y cholecysto-
jejunostomy can be an extremely difficult 
added procedure at the end of a long and 
arduous liver transplantation. The typical 
adult liver recipient is dying of hepatic fail-
ure and has massive collaterals in the small-
bowel mesentery. In addition, the mesentery 
is usually thickened and waterlogged with 
edema fluid. Construction of a Roux-en-Y 
isolated limb under these conditions may 
require 3 to 6 additional hours of operating 
time in a patient who has already sustained 
thousands of milliliters of blood loss. Under 
these adverse conditions, it may be the 
better part of valor to perform a simple 
cholecystoduodenostomy with the objective 
of returning later. 
If at the time of transplantation the gall-
bladder were found to be defective, we 
would them make a selection between 
choledochocholedochostomy with T -tube 
stenting, and a Roux-en-Y choledocho-
jejunostomy. 
No matter what the initial procedure, an 
intense suspicion about the cause for post-
operative jaundice is a necessary condition 
of postoperative management. The simplest 
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precaution is to perform routine intra-
venous cholangiography in the early post-
operative period (Fig. 3A). In almost allof~ 
our patients who develop jaundice, trans-
hepatic cholangiography (Fig. 3B) and per-
cutaneous needle biopsy are now performed. 
Cholangiography has been greatly expe-
dited by our use of the Chiba needle intro-
duced in Japan 6•7 and now being used in 
several American centers. These thin-walled 
small-caliber needles have great flexibility 
that permits the diagnostic studies to be 
done with an improvement in safety (Fig. 
38). 
I t is not yet established that these changes 
in policy will improve the results after liver 
transplantation. Our approach is funda-
mentally different from that proposed by 
Caine. who believes that duct-to-duct re-
construction over a T-tube and preservation 
of the sphincter of Oddi will be the better 
solution.s The fact that different methods 
are being tried to solve a generally recog-
nized set of problems should be of advan-
tage in evolving solutions that can even-
tually be agreed upon. 
HYPERACUTE REJECTION 
The pathophysiology of hyperacute rejec-" 
tion has been well worked out in recent .. 
years. Fixation of antibody to the trans-
I~"!ir~ plant is apparently the initiating event, 
was first noted in kidney homografts 
breaches of red-blood-type barriers.9 
later years the predominant cause of 
acute rejection has been the presence in 
recipient of antigraft cytotoxic 
as was first described by Terasaki 10 
confirmed by Kissmeyer-Nielsen II 
others. 12.14 
In experimental animals of widely 
parate relationship, an experiment of 
with hyperacute rejection may be 
structed, as for example in 
organs from pigs to dogs. IS The 
dogs contains heterospecific 
cytotoxic antibodies. 
With either homografts or 
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Table ... Three ea ... of Orthotopic Tran.plantation of ABO-incompatible Live" 
ABO Types Preoperative OT Isoagglutinin 
Diagnosis Donar Recipient Titer 
11/12 Biliary atresia AB-A 1:4 (anti-B) 
46 Primary biliary AB-A 1 :32 (anti-B) 
cirrhosis 
42 Postneerotic A-O 1:512 
cirrhosis (anti-A) 
transplanted to recipients that possess pre-
formed antigraft antibodies, the actual de-
struction of the homograft or heterograft is 
a complex process in which formed blood 
elements and clotting factors are entrapped 
. by the graft. 13-15 The resulting occlusion of 
the major vessels causes ischemic necrosis 
and a characteristic purple or mottled ap-
pearance. 
It is probable that the kidneys, because of 
the special filtering properties of the renal 
microvasculature, are unusually prone to 
the irreversible consequences of hyperacute 
rejection. I n contrast, the liver may be un-
usually resistant, as the ability of pig livers 
to perform rudimentary functions for a 
number of hours while being perfused with 
human blood might have predicted. 16 Even 
in the difficult pig-to-dog heterograft model 
. in which kidneys are grossly rejected in a 
few seconds the liver often does not suffer 
this fate for more than an hour. i5 
The resistance of the liver to hyperacute 
rejection may prove to be sufficiently great 
to permit transplantation under conditions 
that would be categorically unacceptable 
for kidneys. If so, an important stricture 
on the practicality of the procedure will be 
eased. Patients dying of liver disease usually 
cannot wait for an ideal homograft. If trans-
plantation could be conducted in spite of 
preformed antibody states, .. patients de-
prived in the past of a trial at treatment 
would no longer be arbitrarily excluded. In 
Survival 
(dCl)'l) Cau .. of Death Pathologic Cho_ in li_ 
173 Septicemia (from (Arterial and arteriolar 
liver?) narrowing (past rejection) 
61 Septicemia (from Mild cytomegaloviral in-
liver?) fection 
Pulmonary emboli No rejection 
41 Disseminated herpes Cytomegalovirus infection 
and cytomegalo· No rejection 
virus 
Pulmonary emboli 
Brain infarction 
this connection, our previously unreported 
experience is of potential interest. 
ABO incompatibility. In 1972,3 patients 
with ABO-mismatched livers were trans-
planted to recipients whose conditions were 
considered sufficiently grave that they could 
not wait (Table 4). Hyperacute rejection did 
not occur, and no obvious adverse conse-
quences were seen. The titers of antigraft 
isoagglutinins were highly variable, and at 
Table 5. Sorial Antigraft I_gglutinin Tite" in the 
Three Recipient' of ABO-incompatible Live" 
DolCribod in Table" 
OT 59 OT6O OT61 
Post·transplantation Oay (Anti·8) (Anti·8) (Anti·A) 
0 1,4 1:32 1:512 
1,4 1,16 
3 1,1 1:4 1:64 
5 1: 1 1:2 1:64 
7 1,1 1:8 1:2048 
9 1:4 1:64 1:8192 
11 1:4 1,64 1,8192 
13 1,4 1:32 1:4096 
15 1:4 1,16 1,2048 
17 1 :8 1:1024 
19 1,2 1,4 1: 1024 
21 1: 1 1,4 1,512 
28 1: 1 1,2 1,256 
35 1:2 1,2 1,128 
42 1 :2 1,2 
49 1:2 1: 1 
56 1:2 1:8 
63 1:2 
70 1:2 
77 1:8 
84 1,4 
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least in one case reached prodigious levels 
(Table 5). Eventually the three patients all 
died, but the pathologic findings were re-
markably minor. The homograft of I of the 
patients (OT 60) became partially ob-
structed by the mechanism of cystic duct 
stenosis shown in Fig. 2B; following biliary 
reconstruction, the recipient died of pul-
monary sepsis. The other 2 patients had al-
most no abnormalities in their livers when 
they died of infectious complications. 
Cytotoxic antibodies. This ability of the 
liver to remain healthy under conditions 
that would be predictably harmful to most 
kidneys is a noteworthy feature that has 
been seen in other preformed antibody situ-
ations. During the last 2 years, 3 patients 
with antidonor cytotoxic antibodies have 
been given livers. In all 3 cases cytotoxins 
were also present against most of the do-
nors of an indifferent lymphocyte screening 
panel. Thus the prospects of finding a liver 
without a positive cytotoxic antibody cross-
match were considered nil. As a conse-
quence. a decision was made to proceed de-
spite the potentially adverse prognostic 
implications. 
None of the 3 patients developed hyper-
acute rejection, although they all eventually 
died from 31 weeks to 131 months later 
(Table 6), in 2 cases with relatively good 
livers. In OT 71, the homograft seemed to 
have been severely damaged by ischemia, 
as well as cellular rejection. although its 
poor initial function could have been a 
manifestation of acute antibody-mediated 
i injury. After 10 days the organ was re-
moved and replaced by a chimpanzee het-
erograft. against which the recipient cyto-
toxins also reacted. The chimpanzee liver 
functioned for most of the 14 subsequent 
days of the patient's life. Upon pathologic 
examination the initial homograft had 
many focal areas of necrosis compatible 
137 
with the diagnosis of ischemic injury. In 
contrast, the heterograft was well preserved. 
Centrilobular cholestasis was a prominent 
feature. Otherwise, there was little evidence 
of rejection. This was our third trial of 
chimpanzee-to-man heterotransplantation, 
the other two having been previously re-
ported. I•17 
It goes without saying that preformed 
antibody states should be avoided if at all 
possible. However, the experience cited 
both with the ABO red cell and cytotoxic 
antibodies makes it possible that this kind 
of positive cross-match is not an absolute 
but only a relative contraindication for liver 
transplantation. 
SUMMARY 
An account of 82 consecutive orthotopic 
liver transplantations carried out in Colo-
rado is given. Eighteen patients have lived 
for I year postoperatively, and the longest 
survival is almost 5 years. 
Much of the high failure rate is attribut-
able to the technical difficulty of the opera-
tion and especially to complications of the 
biliary duct reconstruction. A strategy for 
biliary duct reconstruction is advanced that 
is designed to place the liver as far outside 
the mainstream gastrointestinal tract as 
possible, to avoid unnecessary sacrifice of 
biliary duct tissue and to facilitate reopera-
tion at the slightest sign of a technical 
complication. 
An experience is cited in 6 patients who 
received 6 homografts and I chimpanzee 
heterograft in which livers were trans-
planted against preferred anti-red-cell isoag-
glutinins or leukocyte cytotoxins. Hyper-
acute rejection did not occur, nor was there 
convincing evidence of antibody-mediated 
rejection in any case. The conclusion is that 
the liver may be more resistant to hyper-
acute rejection than is the kidney. 
--- --------------
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DISCUSSION 
DR. CALNE: Tom, I would [ike to congratulate 
you on the tremendous amount of work that you pre-
sented here. I think that the conclusions that you have 
come to about biliary drainage will be very interesting 
to compare with the results you get with the long Roux 
loop and what we get with the T tube. One potential 
advantage of the T tube is that you can do a chol-
angiogram every day if you want to, and you can be 
sure at any rate whether there is a major blockage. 
I think there is one aspect of liver transplant that 
perhaps deserves a little bit of emphasis. and that is 
the diagnosis of rejection. This can be exceedingly diffi-
cult even by biopsy. The changes that can occur in the 
liver are relatively limited, and to give a dogmatic 
opinion that the changes are of rejection. infection, 
drug toxicity, or ischemia can be difficult. At our last 
liver transplantation we had a rather interesting experi-
ence, which you probably have observed also, of a long 
ischemic period. The liver was removed some 60 miles 
away and brought to our hospital, and the behavior of 
it at operation looked fine. The patient became pro-
gressively more and more jaundiced, and the bilirubin 
went up to 40. There was no evidence of rejection on 
the migration of white cells test. which we think is 
quite a useful test. The T-tube cholangiogram showed 
that the ducts were quite normal. We didn't increase 
immunosuppression. We just sat tight and the bili-
rubin came down spontaneously to normal, and the 
patient is out of the hospital now. I think that pre-
viously we would have panicked and given huge 
doses of immunosuppression and probably killed 
the patient with infection. It emphasizes some of the 
discussion that was held this morning about not giv-
ing extensive amounts of immunosuppressive agents. 
The other patient we have living now more than a 
year is not on any steroids at al\, and just on 120 mg 
of Imuran a day. I think that this experience in pa-
tients with livers on lower doses of immunosuppres-
sion than kidneys goes along very well with the ob-
servations that you described of crossing the ABO 
barriers and crossing cross-match barriers. and fits in 
with our own thoughts very closely, both experi-
mentally and clinically; if indeed we can use any kind 
of donor on ABO grounds for liver transplantation 
it would make the procurement of donors and the . 
actual treatment of patients very much easier and be 
a great important logistic advance. _ ":l'-':" 
DR. A. G. BIRTCH: (Springfield) I, like Dr. CafneI"~D 
would like to compliment Tom on a beautiful -p~D:::D;C:I 
sentation. I would have just two comments. 
actually the first liver transplant that we did at 
Brigham was indeed ABO-incompatible. It was B 
and we did indeed find anti-B antibody; and that 
as you recall was one that had suffered siglnifi,canlt; 
ischemic damage. We were never able to put .n.' .... '_' 
whether the findings at day 10 or II when the 
succumbed were due to the ischemic injury, 
we assumed, or had anything to do with the 
titer that was present. I still don't know. If I 
stand your 3 patients correctly, none of them 
long-term survivors. I wondered if there was IIn'"IL"'5 
in the long-term course of those patients 
you think that crossing that barrier had an'vthing 
do with their not becoming long-term 
Second, I would just like to reminisce a bit 
As you remember, Tom, in Dr. Moore's original 
nique he used the Roux-en-Y in the dog for 
years, feeling at that time that it had to be better 
the duodenostomy. One of the things that we did 
in trying to trim the operation down to size 
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pw ..... ·_ .. that technique and go to your technique of 
the gallbladder into the duodenum. I have 
this lesson many times personally; I don't 
whether it is the answer eventually, but I've 
that when I change something that Dr. Moore 
done, I usual\y come back to regret it in the end. 
DR. STARZL: I agree with you about confronting 
Moore's opinion, and I try assiduously to avoid 
As to the Boston case. the blood type direction 
B to A, a detail I know because you and Dr. 
oore made the facts available to me. I have had the 
Io~:aplon recently to go back and look at what you 
me when it was fresh in your mind. That liver 
del,elc)oc:d multiple intrahepatic abscesses as the most 
iml)ortarlt postmortem finding. something that I think 
not necessarily be related to the confrontation 
the blood type. For a long time I thought it would 
unlikely that we should do such red-blood-type 
anymore. but I obviously changed my mind 
extent. The time of death of one of those 
failures was about 40 days. That was the pa-
who had a hepato-renal syndrome that reversed, 
the brain lesion didn't go away. We were left with 
vegetable whose systemic support was eventual\y 
'IIIldll;continuled. The second case was a child with biliary 
._r ... I~K;" who had a perfect result and who died some 7 
later from the kind of complication that ap-
killed Roy Caine's long-surviving patient 
week, and which killed one of our longest sur-
""",",._-- namely septicemia. The third combination was 
AB to A death that occurred about 2 months or so 
pllstopel~atilvellyI and followed an attempt to correct a 
duct obstruction. I think these cases had no 
'M[cvlidence of antibody damage. As to the 3 with cyto-
toxins, only case 3 might have had antibody damage. 
In that liver there are findings that could be explained 
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by immunologic or ischemic damage. I am fascinated 
by Caine's case with the high-titer cytotoxins, and 
although one might become incontinent at the moment 
of revascularization I think I might try confronting a 
cytotoxic cross-match again if I real\y had to do it. 
DR. WOLF: Just two more general questions. One, 
what is your current feeling on transplanting for 
malignant disease'? And secondly. how about your 
current immunosuppression for these patients? 
DR. ST ARZL: I think the patient with malignant 
disease is a bad risk, but it's obviously a matter of 
judgment as a clinician when you are confronted with 
a case; in spite of all kinds of resolutions about not 
wanting to do more tumor cases you end up treating 
the patient. Not long ago I had such a patient with a 
duct-cell carcinoma. I was skiing in Aspen at about 
the time the patient arrived, and when a donor be-
came available I did him because there was a donor 
and because it obviously was his only chance. As a 
matter of fact, I have thought for a long time that this 
kind of neoplasm might be a good indication because 
the tumor itself is so small. At the time of the liver 
replacement in the case I just mentioned, I never had 
a positive tissue diagnosis until the case was all 
finished. Even then the pathologist had to go on a de-
tective hunt to find the tumor. It was very small and 
partly necrotic. The cases that we have had difficulty 
with have been the hepatomas that were already big. 
Even then we know that it is possible to effect a cure. 
Roy's case has demonstrated this. We have a child at 
4 years, 4 months who obviously represents a cure of a 
hepatoma, and there are some othersKar~A few. 
So I think that under properly defined circumstances it 
would be reasonable to do a few of these. and so I 
don't have a closed mind about it. 
